Home › NDC Lookup › RxCUI directory › RxCUI 308769

Bivalirudin 250 MG Injection — RxCUI 308769

Name: Bivalirudin 250 MG Injection (RxCUI 308769)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 308769 Semantic clinical drug · SCD ● Current RxNorm concept 12 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308769

Official nameBivalirudin 250 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbivalirudin 50 MG/ML Injection; bivalirudin 250 MG (as bivalirudin trifluoroacetate 275 MG) per 5 ML Injection

FDA products mapped12

Package NDCs mapped13

Reported Medicaid activity (SDUD)15 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Bivalirudin 250 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Bivalirudin 250 MG Injection RxCUI 308769 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Bivalirudin 60819 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Angiomax 285044 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Bivalirudin Injection 1657991 SCDF
- Bivalirudin Injectable Product 1161844 SCDG
- Bivalirudin Injection [Angiomax] 1657994 SBDF
- Angiomax Injectable Product 1176229 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Bivalirudin 250 MG 1657990 SCDC
- Bivalirudin 250 MG Injection [Angiomax] 284534 SBD
- Bivalirudin 250 MG [Angiomax] 1657993 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Bivalirudin 250 MG SCDC · 1657990
Bivalirudin Injection SCDF · 1657991
Bivalirudin Injectable Product SCDG · 1161844

Brand-Name Concepts

Bivalirudin 250 MG Injection [Angiomax] SBD · 284534
Bivalirudin 250 MG [Angiomax] SBDC · 1657993
Bivalirudin Injection [Angiomax] SBDF · 1657994
Angiomax Injectable Product SBDG · 1176229
Angiomax BN · 285044

📦 FDA Products & Package NDCs

12 products · 13 package NDCs

13 package NDCs map to RxCUI 308769 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
16729-0275-67	10 VIAL, SINGLE-USE in 1 CARTON (16729-275-67) / 5 mL in 1...	Bivalirudin	Accord Healthcare, Inc.	2018-11-07
52958-0034-01	10 VIAL, SINGLE-USE in 1 CARTON (52958-034-01) / 1 INJECTIO...	Bivalirudin	Hainan Shuangcheng Pharmaceuticals Co., Ltd.	2019-10-23
55111-0652-37	10 VIAL, SINGLE-DOSE in 1 CARTON (55111-652-37) / 1 INJECTI...	Bivalirudin	Dr. Reddy's Laboratories Limited	2017-05-31
55150-0210-10	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-210-10) / 1 INJECTI...	BIVALIRUDIN	Eugia US LLC	2018-07-27
63323-0562-10	10 VIAL, SINGLE-USE in 1 CARTON (63323-562-10) / 1 INJECTIO...	Bivalirudin	Fresenius Kabi USA, LLC	2016-10-28
63323-0562-15	10 VIAL, SINGLE-USE in 1 CARTON (63323-562-15) / 1 INJECTIO...	Bivalirudin	Fresenius Kabi USA, LLC	2017-10-30
67457-0256-10	10 VIAL, SINGLE-DOSE in 1 CARTON (67457-256-10) / 5 mL in 1...	Bivalirudin	Mylan Institutional LLC	2018-06-05
70436-0025-80	1 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 VIAL,...	bivalirudin	Slate Run Pharmaceuticals, LLC	2021-06-30
70436-0025-82	10 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 CARTO...	bivalirudin	Slate Run Pharmaceuticals, LLC	2021-06-30
71288-0427-11	10 VIAL, SINGLE-DOSE in 1 CARTON (71288-427-11) / 5 mL in 1...	BIVALIRUDIN	Meitheal Pharmaceuticals Inc.	2018-07-16
71288-0427-92	10 VIAL, SINGLE-DOSE in 1 CARTON (71288-427-92) / 5 mL in 1...	BIVALIRUDIN	Meitheal Pharmaceuticals Inc.	2018-07-16
72572-0035-10	10 VIAL, SINGLE-USE in 1 CARTON (72572-035-10) / 1 INJECTIO...	bivalirudin	Civica, Inc.	2020-12-21
83634-0400-10	10 VIAL, SINGLE-DOSE in 1 CARTON (83634-400-10) / 1 INJECTI...	Bivalirudin	Avenacy, Inc.	2023-12-18

Observed labelers: Fresenius Kabi USA, LLC (2) · Meitheal Pharmaceuticals Inc. (2) · Slate Run Pharmaceuticals, LLC (2) · Accord Healthcare, Inc. (1) · Avenacy, Inc. (1) · Civica, Inc. (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0583	Bivalirudin	11	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.